Global Acetic Acid Market Size & Demand to Surpass USD 13.65 Billion by 2021: Zion Market Research
Oct 26, 2017 13:36 pm UTC| Business
Sarasota, FL, Oct. 26, 2017 -- Zion Market Research has published a new report titled “Acetic Acid Market for VAM, Acetate Esters, Acetic Anhydride, PTA and Other Application: Global Industry Perspective, Comprehensive...
FTJ FundChoice Hits $9 Billion in Assets Under Administration
Oct 26, 2017 13:35 pm UTC| Business
HEBRON, Ky., Oct. 26, 2017 -- FTJ FundChoice, a national turnkey asset management program (TAMP) headquartered in Hebron, KY, announced today that it has surpassed $9B in assets under administration (AUA). The nearly...
Permeate Market to touch US$ 1 Bn by 2027 - Future Market Insights
Oct 26, 2017 13:33 pm UTC| Business
Valley Cottage, NY, Oct. 26, 2017 -- A new research publication titled “Permeate Market: Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2027)” crafted by Future Market Insights unveils various...
Sturgis Bancorp, Inc. Declares Quarterly Cash Dividend
Oct 26, 2017 13:31 pm UTC| Business
STURGIS, Mich., Oct. 26, 2017 -- Sturgis Bancorp, Inc. (OTCQX:STBI) today announced that its Board of Directors has declared a cash dividend of $0.12 per common share, payable December 15, 2017 to stockholders of record...
UPS Forecasts Another Record-Breaking Holiday Shipping Season
Oct 26, 2017 13:30 pm UTC| Business
ATLANTA, Oct. 26, 2017 -- UPS forecasts record holiday delivery of about 750 million packages Deliveries between Black Friday and New Year’s Eve projected to increase 5% from 201617 of 21 holiday delivery days before...
Cyber Security Market Is Projected To Be Around $173.57 Billion By 2022
Oct 26, 2017 13:29 pm UTC| Business
LAS VEGAS, Oct. 26, 2017 -- The global Cyber Security Market was worth USD 58.13 billion in the year 2012 and is expected to reach approximately USD 173.57 billion by 2022, while registering itself at a compound annual...
Oct 26, 2017 13:29 pm UTC| Business
CAMBRIDGE, Mass., Oct. 26, 2017 -- VBI Vaccines Inc. (Nasdaq:VBIV) (TSX:VBV) (VBI), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today...